Search for: "Pharmacia "
Results 21 - 40
of 152
Sort by Relevance
|
Sort by Date
21 Feb 2016, 1:44 am
These factors were then applied for the first time in Actavis v Pharmacia [2014] EWHC 2265 (the history of which is recorded in Rose J's judgment). [read post]
19 Feb 2016, 2:50 pm
RT: [See also the papers in the Xalatan/Travatan case, Pharmacia v. [read post]
9 Nov 2015, 3:37 pm
The Pharmacia Corporation Supplemental Pension Plan is operated by Pfizer and it is a non-qualified pension benefit. [read post]
5 Nov 2015, 9:50 am
”Pharmacia & Upjohn Co. v. [read post]
16 Jun 2015, 7:22 am
Pharmacia Corp. v. [read post]
26 May 2015, 7:42 am
Recently, Bexis attended the DRI drug and device committee spring conference. [read post]
7 Nov 2014, 5:52 am
We’ve made no secret of our distaste for the so called “heeding presumption” – that juries may presume that any alternative “adequate” warning would have been heeded by the plaintiff (or, in prescription medical product cases, the prescriber). [read post]
3 Nov 2014, 11:10 am
Others include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) What is the next step? [read post]
22 Jul 2014, 10:17 am
While AndroGel (Abbvie/Abbott) is one of the most popular of these treatments, they also include: Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/Glaxo) Testopel (Auxilium) The gist of it is that low testosterone treatments may double the risk of heart attack for young men with heart disease as well as for men 65 years of age and older,… [read post]
15 Jul 2014, 11:44 pm
Today I conclude my three-part series on mergers and acquisitions under the Foreign Corrupt Practices Act (FCPA) with a review of the post-acquisition phase. [read post]
16 Apr 2014, 5:35 am
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Researchers have long suspected a link between testosterone treatment and the risk of heart attack, though millions of men who have been taking the hormonal treatments are just now learning of the… [read post]
9 Apr 2014, 5:00 am
Damien Geradin, George Mason University School of Law; Tilburg University - Tilburg Law and Economics Center (TILEC); Covington & Burling LLP describes When Competition Law Analysis Goes Wrong – The Italian Pfizer/Pharmacia Case. [read post]
28 Feb 2014, 1:36 pm
The following products are included with those that could be causing serious and fatal injuries: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Despite this controversy, testosterone supplementation in the United States has increased substantially over the past several… [read post]
18 Feb 2014, 3:18 pm
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
18 Feb 2014, 3:18 pm
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
18 Feb 2014, 3:18 pm
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
18 Feb 2014, 3:18 pm
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
19 Dec 2013, 4:56 pm
(Enlarged Board of Appeal in G2/98).Priority can be lost by:narrowing down the disclosure from the priority document in a manner which the invention could not be derived directly and unambiguously from it (Pharmacia Corp v Merck & Co Inc [2002] RPC 41); orwidening or generalizing from the priority disclosure (Beloit Technologies Inc and another v Valmet Paper Machinery Inc and another [1995] RPC 7005 and Unilin)The story continues in Part II. [read post]
8 Jun 2013, 10:35 am
Sugen’s appeal against the revocation was fixed for hearing on May 14th 2013 subject to the undertaking given by the appellant (Sugen) that they will not use the revoked patent against the second respondent (Cipla) in other proceedings.According to the appellant (Sugen/Pharmacia) the opposition was not sustainable (second revocation decision) due to the following grounds, which are detailed below:Consideration of Section 25(2) (b):Sugen argued that Section 25(2) (b) should have not… [read post]
7 May 2013, 8:53 am
I do not detect anything in the decisions of the Court of Appeal in Pharmacia and Unilin Beheer which is inconsistent with this approach and in my judgment is one which this court should adopt. [read post]
